Zobrazeno 31 - 40
of 336
pro vyhledávání: ''
Autor:
Helena Hwang, Brian Z. Ring, Marshall T Schreeder, Nancy Watroba, Robert S. Seitz, Christine Murekeyisoni, Swati Kulkarni, Noel C Estopinal, Douglas T. Ross, David G. Hicks, Thaer Khoury, Rodney A. Beck
Publikováno v:
Breast Cancer Research : BCR
Introduction The addition of taxanes (Ts) to chemotherapeutic regimens has not demonstrated a consistent benefit in early-stage breast cancer. To date, no clinically relevant biomarkers that predict T response have been identified. Methods A dataset
Publikováno v:
Breast Cancer Research : BCR
Introduction New signaling pathways of the interleukin (IL) family, interferons (IFN) and interferon regulatory factors (IRF) have recently been found within tumor microenvironments and in metastatic sites. Some of these cytokines stimulate while oth
Publikováno v:
Breast Cancer Research : BCR
Background It is known that use of hormone replacement therapy (HRT) by postmenopausal women increases the risk of breast cancer. Method In this study, oestrogen receptor (ER)-α expression is examined using standard immunoperoxidase technique. Resul
Publikováno v:
Breast Cancer Research : BCR
The aim of this study is to compare the performance of Sectra and Hologic digital mammography, two different technologies introduced to Breast Test Wales in 2012 for breast cancer screening. Specifically, any variation in findings and whether differe
Publikováno v:
Breast Cancer Research : BCR
Introduction Transducin (β)-like 1 X-linked receptor 1(TBLR1) is an F-box-like and WD repeat-containing protein which functions as a switch in transcriptional activation, However, the clinical significance and biological role of TBLR1 in breast canc
Autor:
Deirdre Cronin-Fenton, Timothy L. Lash, Søren Friis, John A. Baron, Henrik Toft Sørensen, Lars Pedersen
Publikováno v:
Breast Cancer Research : BCR
Cronin-Fenton, D, Pedersen, L, Lash, T L, Friis, S, Baron, J A & Sørensen, H T 2010, ' Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study ', Breast Cancer Research (Online Edition), vol. 12, no. 2, pp. R15 . https://doi.org/10.1186/bcr2482
Cronin-Fenton, D, Pedersen, L, Lash, T L, Friis, S, Baron, J A & Sørensen, H T 2010, ' Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study ', Breast Cancer Research (Online Edition), vol. 12, no. 2, pp. R15 . https://doi.org/10.1186/bcr2482
Udgivelsesdato: 2010-Mar-1 ABSTRACT: INTRODUCTION: Non-steroidal anti-inflammatory drugs (NSAIDs) prevent the growth of mammary tumours in animal models. Two population-based case-control studies suggest a reduced risk of breast cancer associated wit
Autor:
Xuewen Gu, Rong Zhang, Chengming Wang, Jingting Jiang, Xiulong Xu, Yi Yang, Yufang Shi, Ke Huang, Jilei Zhang, Weihong Sun
Publikováno v:
Breast Cancer Research. 18(1)
Since Francis Peyton Rous’s landmark study of identifying avian oncogenic virus, seven viruses have been found to cause 10–15 % of human cancers worldwide [1]. Recent findings by Buehring’s group have suggested that another virus, bovine leukem
Autor:
Tejal Patel, Jenny C. Chang, Angel Rodriguez, Gerardo Colon-Otero, Edith A. Perez, Bhuvanesh Dave
Publikováno v:
Breast Cancer Research : BCR
The estrogen receptor and human epidermal growth factor receptor (HER) signaling pathways are the dominant drivers of cell proliferation and survival in the majority of human breast cancers. Not surprisingly, targeting these pathways provides the mos
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
Autor:
Brian M Nolen, Jeffrey R Marks, Shlomo Ta'san, Alex Rand, The Minh Luong, Yun Wang, Kimberly Blackwell, Anna E Lokshin
Publikováno v:
Breast Cancer Research : BCR
Introduction Neoadjuvant chemotherapy has become the standard of care for the diverse population of women diagnosed with locally advanced breast cancer. Serum biomarker levels are increasingly being investigated for their ability to predict therapy r
Autor:
Yeun-Chung Chang, Chiun-Sheng Huang, Yu-Sen Huang, Wei-Chun Ko, Yao-Hui Tseng, Jenny Ling-Yu Chen, Sung-Hsin Kuo, Fu-Shan Jaw
Publikováno v:
Breast Cancer Research : BCR
We aimed to evaluate the influence of mammographic breast density at diagnosis on the risk of cancer recurrence and survival outcomes in patients with invasive breast cancer after modified radical mastectomy. This case-control study included 121 case